Role of Epstein-Barr Virus in the Development of Nasopharyngeal Carcinoma.

about

Role of Epstein-Barr Virus in the Development of Nasopharyngeal Carcinoma.

Item

http://www.wikidata.org/entity/Q50878798

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Role of Epstein-Barr Virus in the Development of Nasopharyngeal Carcinoma.

@en

Role of Epstein-Barr Virus in the Development of Nasopharyngeal Carcinoma.

@nl

type

Item

label

Role of Epstein-Barr Virus in the Development of Nasopharyngeal Carcinoma.

@en

Role of Epstein-Barr Virus in the Development of Nasopharyngeal Carcinoma.

@nl

prefLabel

Role of Epstein-Barr Virus in the Development of Nasopharyngeal Carcinoma.

@en

Role of Epstein-Barr Virus in the Development of Nasopharyngeal Carcinoma.

@nl

P1476

Role of Epstein-Barr Virus in the Development of Nasopharyngeal Carcinoma.

@en

P2093

Dan Yu

http://www.w3.org/2001/XMLSchema#string

Hui Zhang

http://www.w3.org/2001/XMLSchema#string

Jing Wang

http://www.w3.org/2001/XMLSchema#string

Kai Xue

http://www.w3.org/2001/XMLSchema#string

Xue Zhao

http://www.w3.org/2001/XMLSchema#string

Yan Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells

Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma

Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.

A human Fab-based immunoconjugate specific for the LMP1 extracellular domain inhibits nasopharyngeal carcinoma growth in vitro and in vivo.

Epstein-Barr virus-encoded latent membrane protein 2A promotes the epithelial-mesenchymal transition in nasopharyngeal carcinoma via metastatic tumor antigen 1 and mechanistic target of rapamycin signaling induction.

Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells.

Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells.

Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.

Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.

T cells expressing a LMP1-specific chimeric antigen receptor mediate antitumor effects against LMP1-positive nasopharyngeal carcinoma cells in vitro and in vivo.

P304

171-176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1515/MED-2017-0025

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28730175

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

P932

5471915

http://www.w3.org/2001/XMLSchema#string